Ethiopia vs Marshall Islands: Immunization, Hib3
Ethiopia
73.0%
in 2024
Marshall Islands
72.0%
in 2024
Ethiopia rank
157th
Marshall Islands rank
160th
Immunization, Hib3 over time
- Ethiopia
- Marshall Islands
How they compare
Ethiopia currently reports 73.0% against 72.0% in Marshall Islands, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2007 it was Marshall Islands ahead.
Ethiopia ranks 157th and Marshall Islands ranks 160th of 191 countries.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.7% | 91.3% | 39.7% | Marshall Islands |
| 2010s | 62.2% | 70.7% | 8.5% | Marshall Islands |
| 2020s | 66.2% | 71.8% | 5.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Ethiopia or Marshall Islands?
- Ethiopia, at 73.0% against 72.0% in Marshall Islands as of 2024.
- What is the difference in immunization, hib3 between Ethiopia and Marshall Islands?
- 1.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Marshall Islands?
- 18 years are reported by both, from 2007 to 2024.
- How do Ethiopia and Marshall Islands rank globally for immunization, hib3?
- Ethiopia ranks 157th and Marshall Islands ranks 160th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.